^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Muscarinic receptor antagonist

    Related drugs:
    23h
    A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD (clinicaltrials.gov)
    P2, N=480, Recruiting, Verona Pharma plc | Trial completion date: Apr 2026 --> Jul 2026 | Trial primary completion date: Apr 2026 --> Jul 2026
    Trial completion date • Trial primary completion date
    3d
    Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE] (clinicaltrials.gov)
    P=N/A, N=44, Completed, Yonsei University | Not yet recruiting --> Completed
    Trial completion
    4d
    A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD (clinicaltrials.gov)
    P3, N=487, Completed, Haisco Pharmaceutical Group Co., Ltd. | Recruiting --> Completed | Trial primary completion date: Oct 2025 --> May 2025
    Trial completion • Trial primary completion date
    17d
    Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (clinicaltrials.gov)
    P4, N=93, Recruiting, Iuliu Hatieganu University of Medicine and Pharmacy | Not yet recruiting --> Recruiting
    Enrollment open
    17d
    CHOROS: Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting (clinicaltrials.gov)
    P=N/A, N=2000, Recruiting, AstraZeneca | Trial completion date: Sep 2026 --> Dec 2026 | Trial primary completion date: Sep 2026 --> Dec 2026
    Trial completion date • Trial primary completion date • Real-world evidence
    17d
    Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma (clinicaltrials.gov)
    P4, N=1366, Active, not recruiting, GlaxoSmithKline | Trial completion date: Jan 2026 --> Mar 2027
    Trial completion date
    17d
    NEFOPAIN kinet: Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology (clinicaltrials.gov)
    P4, N=24, Not yet recruiting, University Hospital, Rouen
    New P4 trial
    17d
    Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH) (clinicaltrials.gov)
    P=N/A, N=200, Recruiting, Chiesi Slovenija, d.o.o.
    New trial • Real-world evidence
    22d
    STRENGTH: Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (clinicaltrials.gov)
    P=N/A, N=281, Completed, Chiesi Bulgaria | Active, not recruiting --> Completed
    Trial completion • Real-world evidence
    23d
    INDOS-B: Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease (clinicaltrials.gov)
    P4, N=150, Recruiting, AstraZeneca | Not yet recruiting --> Recruiting
    Enrollment open
    23d
    CHDR2501: Research into new test methods to measure pain with two existing drugs (nefopam and oxycodone) (2025-522389-66-00)
    P1, N=24, Completed, Centre for Human Drug Research | Recruiting --> Completed
    Trial completion
    26d
    TRECONY: Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma (clinicaltrials.gov)
    P2, N=165, Recruiting, Chiesi Farmaceutici S.p.A.
    New P2 trial